Subcutaneous dose
Showing 1 - 25 of >10,000
IBD, Crohn Disease, Ulcerative Colitis Trial (Infliximab)
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- (no location specified)
Oct 27, 2023
Hepatic Impairment, Healthy Volunteers Trial in München, Gdansk, Bratislava (NNC0194-0499)
Not yet recruiting
- Hepatic Impairment
- Healthy Volunteers
-
München, Germany
- +2 more
Jun 27, 2023
Healthy Participants Trial in Sumida-ku (AZD2693, Placebo)
Active, not recruiting
- Healthy Participants
- AZD2693
- Placebo
-
Sumida-ku, JapanResearch Site
Jan 18, 2023
Healthy Men Trial in Hefei (BAT1806 prefilled subcutaneous injection/RoActemra® (from EU))
Not yet recruiting
- Healthy Men
- BAT1806 prefilled subcutaneous injection/RoActemra® (from EU)
-
Hefei, Anhui, ChinaThe Second Affiliated Hospital of Anhui Medical University
Jul 27, 2023
Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- STSA-1301 subcutaneous injection
- Placebo
-
Beijing, Chaoyang District, ChinaBeijing Ditan Hospital,Capital Medical University
Nov 28, 2023
Healthy Volunteers Trial in Hialeah (Amlitelimab DP1, Amlitelimab DP2)
Active, not recruiting
- Healthy Volunteers
- Amlitelimab DP1
- Amlitelimab DP2
-
Hialeah, FloridaClinical Pharmacology of Miami-Site Number: 8400001
Mar 29, 2023
Inflammatory Bowel Disease Trial in Beijing (450mg, 150mg, Placebo)
Completed
- Inflammatory Bowel Disease
- 450mg
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jul 7, 2022
Antineutrophil Cytoplasmic Antibody Associated Vasculitis Trial in Overland Park (STSA-1002 subcutaneous injection)
Recruiting
- Antineutrophil Cytoplasmic Antibody Associated Vasculitis
- STSA-1002 subcutaneous injection
-
Overland Park, KansasAltaSciences Clinical Kansas, Inc
Feb 2, 2023
Non-alcoholic Steatohepatitis (NASH) Trial in Berlin (NNC0194-0499)
Not yet recruiting
- Non-alcoholic Steatohepatitis (NASH)
-
Berlin, GermanyNovo Nordisk Investigational Site
Feb 17, 2023
Healthy Subjects Trial in SEoul (C1K, Placebo)
Recruiting
- Healthy Subjects
- C1K
- Placebo
-
SEoul, Korea, Republic ofSeoul National University Clinical Trial Center
Aug 3, 2023
Achondroplasia Trial in Dallas (BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe)
Recruiting
- Achondroplasia
- BMN 111 administration via Injector Pen
- BMN 111 administration via vial and syringe
-
Dallas, TexasLabcorp
Apr 2, 2023
Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)
Recruiting
- Alzheimer Disease
- GB-5001A
- +2 more
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Nov 17, 2023
Healthy Participants Trial in Cincinnati (Olezarsen)
Recruiting
- Healthy Participants
-
Cincinnati, OhioMedpace Clinical Pharmacology Unit
Nov 29, 2022
Progressive Multiple Sclerosis Trial in Berlin (GZ402668, Placebo, Acyclovir)
Completed
- Progressive Multiple Sclerosis
- GZ402668
- +2 more
-
Berlin, GermanyInvestigational Site Number 276001
Apr 22, 2022
Type 1 Diabetes, Type 2 Diabetes, Hyperglycemia Trial in Winston-Salem (Libre 2.0 CGM in patients taking subcutaneous insulin
Not yet recruiting
- Type 1 Diabetes Mellitus
- +2 more
- Libre 2.0 CGM in patients taking subcutaneous insulin with concomitant high dose glucocorticoids
-
Winston-Salem, North CarolinaWakeForest University Health Sciences
May 11, 2023
Healthy Trial in Ahmedabad (Enoxaparin Sodium (Venus Remedies Limited), Enoxaparin Sodium (Sanofi))
Completed
- Healthy
- Enoxaparin Sodium (Venus Remedies Limited)
- Enoxaparin Sodium (Sanofi)
-
Ahmedabad, Gujarat, IndiaCliantha Research Limited
Mar 2, 2022
Healthy Trial in Shenzhen (TB001, Placebo)
Recruiting
- Healthy
- TB001
- Placebo
-
Shenzhen, Guangdong, ChinaShenzhen Turier Biotech Co., Ltd.
Apr 4, 2022
Healthy Volunteers Trial in Madrid (PBP1502, EU-licensed Humira, US-licensed Humira)
Recruiting
- Healthy Volunteers
- PBP1502
- +2 more
-
Madrid, SpainUnidad de Fase I. U. Autonoma de Madrid (Clinical Trials Unit, U
Sep 26, 2022